Antares Pharma is a pharmaceutical technology company focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Co.'s injection technology platforms include the VIBEX® and VIBEX® QuickShot® pressure-assisted auto injector systems suitable for branded and generic injectable drugs in unit dose containers as well as disposable multi-dose pen injectors. Co.'s products include XYOSTED® (testosterone enanthate) injection, which is use for subcutaneous administration of testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. We show 41 historical shares outstanding datapoints in our ATRS shares outstanding history coverage, used to compute ATRS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ATRS market cap history over the course of time is important for investors
interested in comparing ATRS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ATRS versus a peer is one thing; comparing
ATRS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ATRS can fluctuate over the course of history.
With this page we aim to empower investors researching ATRS by allowing them to research the ATRS market cap history. |
Video: The Importance of Market Cap
